David W. Forrest

ORCID: 0000-0001-6052-7179
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS Research and Interventions
  • Opioid Use Disorder Treatment
  • HIV Research and Treatment
  • Sex work and related issues
  • Forensic Toxicology and Drug Analysis
  • Homelessness and Social Issues
  • Substance Abuse Treatment and Outcomes
  • HIV-related health complications and treatments
  • Health Policy Implementation Science
  • Mental Health Treatment and Access
  • Hepatitis C virus research
  • Reproductive tract infections research
  • Neuropeptides and Animal Physiology
  • Migration, Health and Trauma
  • Mental Health and Patient Involvement
  • HIV/AIDS drug development and treatment
  • Healthcare Policy and Management
  • Torture, Ethics, and Law
  • Primary Care and Health Outcomes
  • Healthcare cost, quality, practices
  • Veterinary Pharmacology and Anesthesia
  • Criminal Justice and Corrections Analysis
  • Crime Patterns and Interventions
  • COVID-19 and Mental Health

University of Miami
2016-2025

Florida State University
2019-2022

Office of Science
2019

Center for Surveillance, Epidemiology, and Laboratory Services
2019

AID Atlanta
2019

In 2017, preliminary data show that gay, bisexual, and other men who have sex with (MSM) accounted for 67% of new diagnoses human immunodeficiency virus (HIV) infection, MSM inject drugs an additional 3%, African American/black (black) Hispanic/Latino (Hispanic) were disproportionately affected (1). During 2010-2015, racial/ethnic disparities in HIV incidence increased among MSM; 2015, rates black Hispanic 10.5 4.9 times as high, respectively, the rate white (compared 9.2 3.8 2010) (2)....

10.15585/mmwr.mm6837a2 article EN MMWR Morbidity and Mortality Weekly Report 2019-09-19

Sexually transmitted diseases (STDs) disproportionately affect gay, bisexual, and other men who have sex with (MSM) in the United States (1). Because chlamydia gonorrhea at extragenital (rectal pharyngeal) anatomic sites are often asymptomatic, these serve as a reservoir of infection, which might contribute to gonococcal antimicrobial resistance (2) increased risk for human immunodeficiency virus (HIV) transmission acquisition (3). To ascertain prevalence STDs, MSM attending community venues...

10.15585/mmwr.mm6814a1 article EN MMWR Morbidity and Mortality Weekly Report 2019-04-11

Abstract Objectives The COVID-19 pandemic led to the closure of IDEA syringe services program medical student-run free clinic in Miami, Florida. In an effort continue serve community people who inject drugs and practice compassionate non-judgmental care, students transitioned a model TeleMOUD (medications for opioid use disorder). We describe development implementation telemedicine through academic center-operated program. Methods Students advertised at service on social media created online...

10.1186/s12954-020-00438-4 article EN cc-by Harm Reduction Journal 2020-11-17

Abstract Introduction A recent surge in HIV outbreaks, driven by the opioid and stimulant use crises, has destabilized our progress toward targets set forth Ending Epidemic: Plan for America high-priority community of people who inject drugs (PWID), particularly Black PWID. Methods In order to ascertain acceptability feasibility using a mobile syringe services program (SSP) comprehensive prevention via PrEP medications disorder (MOUD), mixed methods approach included quantitative assessment...

10.1186/s12954-022-00721-6 article EN cc-by Harm Reduction Journal 2022-12-03

Introduction: Despite the effectiveness of oral pre-exposure prophylaxis (PrEP) for HIV prevention, knowledge, and uptake this new prevention intervention over time has not been fully studied. Using NHBS data from 2 urban areas highly impacted by HIV, we examined awareness, use, willingness to use daily PrEP factors associated with take among men who have sex (MSM) time. Methods: MSM Washington, DC Miami, FL were recruited in 2011 2014 using venue-based sampling. Participants completed...

10.1097/qai.0000000000001414 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2017-06-09

Abstract Prevention of HIV outbreaks among people who inject drugs remains a challenge to ending the epidemic in United States. The first legal syringe services program (SSP) Florida implemented routine screening 2018 leading identification ten anonymous seroconversions. SSP collaborated with Department Health conduct an epidemiologic investigation. All seven acute seroconversions were linked care (86% within 30 days) and achieved viral suppression (mean 70 days). Six individuals are...

10.1007/s10461-019-02680-9 article EN cc-by AIDS and Behavior 2019-09-25

Injection drug use (IDU) remains a significant public health problem. IDU has been associated closely with the opioid crisis; driving overdose, HIV, and Hepatitis C (HCV) infection nationwide. Syringe services programs (SSPs) remain pivotal evidence-based interventions to reduce harm engage subgroups of people who inject drugs (PWID). This study aims provide policy considerations from IDEA SSP, first legal SSP in state Florida.

10.1016/j.drugpo.2020.102716 article EN cc-by International Journal of Drug Policy 2020-03-05

Background People who inject drugs (PWID) living with HIV are less likely to receive care at early disease stages and have low rates of viral suppression. This study examined the feasibility acceptability rapid antiretroviral therapy (ART) initiation among PWID a syringe services program (SSP) assessed retention in after transition traditional clinic.

10.1080/07853890.2025.2461670 article EN cc-by-nc Annals of Medicine 2025-02-10

Background In the United States, Latino men who have sex with (MSM) are disproportionately affected by HIV. MSM a diverse group differ culturally based on their countries or regions of birth and time in States. We assessed differences HIV prevalence testing among location birth, since arrival, other social determinants health. Methods For 2008 National Behavioral Surveillance System, cross-sectional survey conducted large US cities, were interviewed tested for infection. used generalized...

10.1371/journal.pone.0073779 article EN cc-by PLoS ONE 2013-09-03

Blood-borne viral infections, such as HIV and hepatitis C (HCV), are common infections among people who inject drugs (PWID). This study aims to determine the prevalence of HCV infection PWID accessing first legal syringe services program (SSP) in state Florida, along with examining baseline correlates infection.Baseline behavioral enrollment assessments 837 participants an SSP for time were analyzed. Patients self-reporting or testing positive at visit included. Socio-demographic, drug use,...

10.1186/s12954-020-00385-0 article EN cc-by Harm Reduction Journal 2020-06-10

Background People who inject drugs (PWID) are at an increased risk for HIV infection due to injection and sexual behaviors. This study aims examine PrEP knowledge, awareness, willingness be linked services a syringe program (SSP), the relationship between substance use interest in linkage. Methods Data were collected using cross-sectional survey of IDEA SSP clients Miami, FL (N = 157). Based on reported injected, participants classified into opioid-only or polysubstance injection....

10.1371/journal.pone.0231424 article EN cc-by PLoS ONE 2020-04-16

Abstract Background Tele-harm reduction (THR) is a telehealth-enhanced, peer-led, harm intervention delivered within trusted syringe services program (SSP) venue. The primary goal of THR to facilitate linkage care and rapid, enduring virologic suppression among people who inject drugs (PWID) with HIV. An SSP in Miami, Florida, developed circumvent pervasive stigma the traditional healthcare system. Methods During development, we conducted in-depth interviews PWID HIV ( n = 25) identify...

10.1186/s12954-024-00961-8 article EN cc-by Harm Reduction Journal 2024-02-23

Abstract Background People who inject drugs (PWID) remain a high priority population under the federal Ending HIV Epidemic initiative with 11% of new infections attributable to injection drug use. There is critical need for innovative, efficacious, scalable, and community-driven models healthcare in non-stigmatizing settings PWID. We seek test Comprehensive-TeleHarm Reduction (C-THR) intervention prevention services delivered via syringe program (SSP). Methods The CHARIOT trial hybrid type I...

10.1186/s13722-024-00447-9 article EN cc-by Addiction Science & Clinical Practice 2024-03-25

In March of 2016, Florida passed the Infection Disease Elimination Act (IDEA), legalizing formation first syringe exchange program in Florida, which opened December 2016 at a fixed site Overtown, Miami. Since that time, expanded April 2017 to include mobile van unit provides same services different locations throughout Miami-Dade County. Trained interviewers conducted face-to-face interviews from all first-time participants IDEA Exchange, both and unit. Among 718 enrollees, 74.8% were male,...

10.1186/s12954-019-0280-z article EN cc-by Harm Reduction Journal 2019-01-23

Hospitalizations for severe injection-related infections (SIRI), such as endocarditis, osteomyelitis, and skin soft tissue (SSTI) are increasingly common. People who inject drugs (PWID) experiencing SIRIs often receive inadequate substance use disorder (SUD) treatment lack of access to harm reduction services. This translates into lengthy hospitalizations with high rates patient-directed discharge, readmissions, post-hospitalization mortality. The purpose this study was describe the...

10.1080/07853890.2021.1993326 article EN cc-by Annals of Medicine 2021-01-01

Abstract Background Medicaid expansion under the Affordable Care Act increased insurance coverage, access to healthcare, and substance use disorder treatment, for many Americans. We assessed differences in healthcare utilization among persons who inject drugs (PWID) by state status. Methods In 2018, PWID were interviewed 22 US cities National HIV Behavioral Surveillance. analyzed data from aged 18–64 years reported illicit of opioids (n = 9957) past 12 months. Poisson regression models with...

10.1093/infdis/jiaa337 article EN public-domain The Journal of Infectious Diseases 2020-06-19

Abstract Background Hospitalizations for severe injection drug use-related infections (SIRIs) are characterized by high costs, frequent patient-directed discharge, and readmission rates. Beyond the health system impacts, these admissions can be traumatizing to people who inject drugs (PWID), often receive inadequate treatment their substance use disorders (SUD). The Jackson SIRI team was developed as an integrated infectious disease/SUD intervention patients hospitalized at a public...

10.1186/s13722-023-00363-4 article EN cc-by Addiction Science & Clinical Practice 2023-02-07

Hepatitis C (HCV) is the most common infectious disease among people who inject drugs (PWID). Engaging PWID in harm reduction services, such as syringe service programs (SSPs), critical to reduce HCV and HIV transmission. Additionally, testing for important improve diagnosis linkage care. On March 1, 2018, Florida's only legal SSP implemented bundled opt-out HIV/HCV at enrollment. We aimed examine differences uptake before after implementation of policy.

10.1016/j.drugpo.2020.102875 article EN cc-by-nc-nd International Journal of Drug Policy 2020-07-27
Coming Soon ...